Impact of Obesity and Weight-Based Chemotherapy Dosing Adjustments on Outcomes of Allogeneic Hematopoietic Cell Transplant Outcomes for Acute Myeloid Leukemia

MLA

Albanyan, Omar, et al. “Impact of Obesity and Weight-Based Chemotherapy Dosing Adjustments on Outcomes of Allogeneic Hematopoietic Cell Transplant Outcomes for Acute Myeloid Leukemia.” Blood, vol. 140, no. 1, Number 1 Supplement 1, Nov. 2022, pp. 7664–66. EBSCOhost, https://doi.org/10.1182/blood-2022-166008.

APA

Albanyan, O., Naqvi, S. M. H., Mo, Q., Belfon, A., Gaskill, E., Nishihori, T., Faramand, R., Lazaryan, A., Hansen, D. K., Khimani, F., Mishra, A., Nieder, M., Perez, L., Liu, H. D., Pidala, J., Anasetti, C., Locke, F. L., Bejanyan, N., & Elmariah, H. (2022). Impact of Obesity and Weight-Based Chemotherapy Dosing Adjustments on Outcomes of Allogeneic Hematopoietic Cell Transplant Outcomes for Acute Myeloid Leukemia. Blood, 140(1, Number 1 Supplement 1), 7664–7666. https://doi.org/10.1182/blood-2022-166008

Chicago

Albanyan, Omar, Syeda Mahrukh Hussnain Naqvi, Qianxing Mo, Athena Belfon, Eric Gaskill, Taiga Nishihori, Rawan Faramand, et al. 2022. “Impact of Obesity and Weight-Based Chemotherapy Dosing Adjustments on Outcomes of Allogeneic Hematopoietic Cell Transplant Outcomes for Acute Myeloid Leukemia.” Blood 140 (1, Number 1 Supplement 1): 7664–66. doi:10.1182/blood-2022-166008.